Newcastle University

Running trials

• Recruiting

  Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

  NCT07151040· Phase 1/2· Source

• Recruiting

  Patient Engagement Investigation of NMS Assist

  NCT07038486· Source

• Recruiting

  FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  NCT06788990· Phase 2/3· Source

• Recruiting

  A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  NCT06680830· Phase 2· Source

• Recruiting

  Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)

  NCT07265596· Phase 2· Source

• Recruiting

  A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

  NCT04775485· Phase 2· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease4 recruiting
• Head and neck cancer2 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Gastric and esophageal cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Phase 2b Study of Zagociguat in Patients With MELAS

  NCT06402123· Phase 2· Source

• Completed

  Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

  NCT05525520· Phase 2· Source

• Completed

  A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

  NCT05348785· Phase 2· Source

• Completed

  Brain Involvement in Dystrophinopathies Part 2

  NCT04668716· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Source

• Completed

  Brain Involvement in Dystrophinopathies Part 1

  NCT04583917· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Source

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· Source

Trial sites

• Institute of Cellular Medicine, Newcastle University1 trial
• University of Newcastle Upon Tyne2 trials
• Clinical Aging Research Unit, Newcastle University1 trial
• Newcastle University10 trials
• Newcastle University, Clinical Ageing Research Unit1 trial
• Newcastle University (Site # 509)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Parkinson disease150 works · 6 trials
• Alzheimer disease118 works · 3 trials
• Duchenne muscular dystrophy46 works · 2 trials
• Lewy body dementia38 works · 0 trials
• Epilepsy38 works · 0 trials
• Kidney cancer30 works · 0 trials
• Fatty liver disease (MASLD/MASH)29 works · 0 trials
• Rheumatoid arthritis27 works · 0 trials
• Primary biliary cholangitis24 works · 1 trials
• Psoriasis20 works · 0 trials
• Neuroblastoma20 works · 0 trials
• Bipolar disorder20 works · 0 trials
• Cystic fibrosis18 works · 0 trials
• Childhood cancers17 works · 1 trials
• Pompe disease15 works · 0 trials
• Head and neck cancer15 works · 2 trials
• Spinal muscular atrophy14 works · 0 trials
• Long COVID and ME/CFS10 works · 0 trials
• Psoriatic arthritis8 works · 0 trials
• Sjögren's disease5 works · 0 trials